Canada - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights
Report Update: May 1, 2024

Canada - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Price for Prophylactic Medicaments Containing Insulin in Canada - 2023

Contents:

  1. Price for Prophylactic Medicaments Containing Insulin in Canada (CIF) - 2022
  2. Price for Prophylactic Medicaments Containing Insulin in Canada (FOB) - 2022
  3. Imports of Prophylactic Medicaments Containing Insulin in Canada
  4. Exports of Prophylactic Medicaments Containing Insulin in Canada

Price for Prophylactic Medicaments Containing Insulin in Canada (CIF) - 2022

The average prophylactic medicaments containing insulin import price stood at $237,383 per ton in 2022, with a decrease of -11.7% against the previous year. Over the period under review, the import price recorded a slight descent. The pace of growth appeared the most rapid in 2021 when the average import price increased by 15%. Over the period under review, average import prices hit record highs at $297,375 per ton in 2018; however, from 2019 to 2022, import prices stood at a somewhat lower figure.

Average prices varied noticeably amongst the major supplying countries. In 2022, amid the top importers, the highest price was recorded for prices from Denmark ($237,407 per ton) and the United States ($237,384 per ton), while the price for France ($237,384 per ton) and Germany ($237,384 per ton) were amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (-1.7%), while the prices for the other major suppliers experienced a decline.

Price for Prophylactic Medicaments Containing Insulin in Canada (FOB) - 2022

The average prophylactic medicaments containing insulin export price stood at $293,010 per ton in 2022, falling by -10.6% against the previous year. Over the period under review, export price indicated a perceptible increase from 2012 to 2022: its price increased at an average annual rate of +4.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin export price increased by +6.6% against 2020 indices. The most prominent rate of growth was recorded in 2018 when the average export price increased by 23% against the previous year. As a result, the export price attained the peak level of $353,107 per ton. From 2019 to 2022, the average export prices failed to regain momentum.

Average prices varied noticeably for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Bermuda ($293,007 per ton), while the average price for exports to the United States stood at $292,995 per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the United States (+4.4%).

Imports of Prophylactic Medicaments Containing Insulin in Canada

Prophylactic medicaments containing insulin imports into Canada skyrocketed to 1.6K tons in 2022, increasing by 32% compared with the year before. The total import volume increased at an average annual rate of +4.4% from 2019 to 2022; the trend pattern remained consistent, with only minor fluctuations being recorded in certain years. As a result, imports attained the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin imports skyrocketed to $391M in 2022. The total import value increased at an average annual rate of +4.3% over the period from 2019 to 2022; the trend pattern remained consistent, with somewhat noticeable fluctuations in certain years. As a result, imports reached the peak and are likely to continue growth in the immediate term.

Import of Prophylactic Medicaments Containing Insulin in Canada (Million USD)
COUNTRY2019202020212022CAGR,
2019-2022
United States14.688.1123186133.6%
Germany12010688.796.4-7.0%
Italy41.345.249.563.715.5%
Brazil54.848.750.933.3-15.3%
France19.034.313.29.2-21.5%
Denmark94.221.310.30.6-81.5%
Others0.33.20.72.294.3%
Total3453473363914.3%

Top Suppliers of Prophylactic Medicaments Containing Insulin to Canada in 2022:

  1. United States (782.6 tons)
  2. Germany (405.9 tons)
  3. Italy (268.3 tons)
  4. Brazil (140.2 tons)
  5. France (38.8 tons)
  6. Denmark (2.7 tons)

Exports of Prophylactic Medicaments Containing Insulin in Canada

In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -51.6% to 14 tons for the first time since 2018, thus ending a three-year rising trend. Over the period under review, exports, however, continue to indicate significant growth. The pace of growth appeared the most rapid in 2020 with an increase of 315% against the previous year.

In value terms, prophylactic medicaments containing insulin exports fell rapidly to $4.2M in 2022. In general, exports, however, showed a significant expansion. The pace of growth appeared the most rapid in 2020 when exports increased by 279%.

Export of Prophylactic Medicaments Containing Insulin in Canada (Million USD)
COUNTRY2019202020212022CAGR,
2019-2022
Bermuda1.21.31.32.222.4%
United States0.43.58.52.071.0%
United KingdomN/A1.7N/AN/A0%
Others0.1N/AN/AN/A0%
Total1.76.59.84.235.2%

Top Export Markets for Prophylactic Medicaments Containing Insulin from Canada in 2022:

  1. Bermuda (7.6 tons)
  2. United States (6.7 tons)

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Canada. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Country coverage:

  • Canada

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Canada
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023
Store
Blog
Event
Canada - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights
$599
May 1, 2024
Eye 296

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Canada.

Canada - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends And Insights
$599
May 1, 2024
Eye 365

This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in Canada.

Canada - Medicaments Containing Vitamins And Provitamins - Market Analysis, Forecast, Size, Trends And Insights
$599
May 3, 2024
Eye 277

This report provides an in-depth analysis of the medicaments containing vitamins market in Canada.

Canada - Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
May 1, 2024
Eye 285

This report provides an in-depth analysis of the market for penicillins or streptomycins medicaments in Canada.

World - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights
$599
May 1, 2024
Eye 445

This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.

World - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends And Insights
$599
May 1, 2024
Eye 502

This report provides an in-depth analysis of the global market for medicaments containing corticosteroid hormones.

World - Medicaments Containing Vitamins And Provitamins - Market Analysis, Forecast, Size, Trends And Insights
$599
May 3, 2024
Eye 633

This report provides an in-depth analysis of the global medicaments containing vitamins market.

World - Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
May 1, 2024
Eye 447

This report provides an in-depth analysis of the global market for penicillins or streptomycins medicaments.

Canada - Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Market Analysis, Forecast, Size, Trends And Insights
$599
May 1, 2024
Eye 296

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Canada.

Canada - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends And Insights
$599
May 1, 2024
Eye 365

This report provides an in-depth analysis of the market for medicaments containing corticosteroid hormones in Canada.

Free Data: Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Canada